The ASX has been up as much as 0.45% at 7,783 points, breaking its Week 11 losing streak on the back of a rally in gold stocks.
Materials has been the best performing sector, up 1.85%, followed by Utilities, up 1.4%, and Industrials, up 0.7%. Energy has been the worst performer, down 0.9%, followed by Telecommunication, down 0.33%, and Information Technology, down 0.25%.
Race Oncology (ASX:RAC) has been the most watched on HotCopper forums today after the company received ethics approval for its Phase One trial in adult solid tumour patients.
Also heavily discussed has been Liontown Resources (ASX:LTR); the long-followed battery minerals producer today released its half year results. The company has maintained a strong cash position with $193 million in the bank.
Also trending: Tivan (ASX:TIV), which was awarded copper-gold exploration licenses in Timor-Leste. The approval has seen Tivan jump 8.5% today.
You’re up to date — see you a little later for HotCopper’s Market Close.
More market news
Together: The U.S. has suspended aid to Ukraine. Will Europe step into the breach?
Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst
Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.